Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Vector Borne Diseases » Leishmaniasis » Leishmaniasis, Cutaneous
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Skin Diseases, Parasitic » Leishmaniasis » Leishmaniasis, Cutaneous
Diseases [C] » Infections [C01] » Parasitic Diseases » Protozoan Infections » Euglenozoa Infections » Leishmaniasis » Leishmaniasis, Cutaneous
Diseases [C] » Infections [C01] » Parasitic Diseases » Skin Diseases, Parasitic » Leishmaniasis » Leishmaniasis, Cutaneous
Description
An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes. MeSH
Hierarchy View
Subtype Terms (2)
Leishmaniasis, Mucocutaneous
7 drugs (4 approved, 3 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (3)
Phase 2 Indicated Drugs (8)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (38)
Cardiovascular Foundation of Colombia
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Drugs for Neglected Diseases Initiative
Federal University of Mato Grosso do Sul
Fundación Cardiovascular de Colombia
Hospital Dermatológico de Jorochito
Instituto Conmemorativo Gorgas de Estudios de la Salud
Instituto de Medicina Integral Professor Fernando Figueira
Instituto Nacional de Infectologia, Brazil
Kerman University of Medical Sciences
Organization Involved with Phase 2 Indications (24)
Fast Track Drugs and Biologics LLC
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
